97 related articles for article (PubMed ID: 22995634)
1. Impact of the epithelial dysplasia grading and Ki67 proliferation index in the adjacent non-malignant mucosa on recurrence and survival in head and neck squamous cell carcinoma.
Pereira CS; Oliveira MV; Fraga CA; Barros LO; Domingos PL; Roy A; De-Paula AM; Guimarães AL
Pathol Res Pract; 2012 Nov; 208(11):651-6. PubMed ID: 22995634
[TBL] [Abstract][Full Text] [Related]
2. P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy.
Lavertu P; Adelstein DJ; Myles J; Secic M
Laryngoscope; 2001 Nov; 111(11 Pt 1):1878-92. PubMed ID: 11801963
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of Ki67 from clinically and histologically 'normal' distant mucosa in patients surgically treated for oral squamous cell carcinoma: a prospective study.
Montebugnoli L; Badiali G; Marchetti C; Cervellati F; Farnedi A; Foschini MP
Int J Oral Maxillofac Surg; 2009 Nov; 38(11):1165-72. PubMed ID: 19615859
[TBL] [Abstract][Full Text] [Related]
4. Heparanase expression in head and neck squamous cell carcinomas is associated with reduced proliferation and improved survival.
Mogler C; Herold-Mende C; Dyckhoff G; Jenetzky E; Beckhove P; Helmke BM
Histopathology; 2011 May; 58(6):944-52. PubMed ID: 21585429
[TBL] [Abstract][Full Text] [Related]
5. Head and neck squamous cell carcinoma in non-smoking and non-drinking patients with multiple tumors: etiologic significance of p53 and Ki-67 in non-tumorous epithelium.
Farshadpour F; Hordijk GJ; Koole R; Slootweg PJ
J Oral Pathol Med; 2008 Oct; 37(9):549-54. PubMed ID: 18331287
[TBL] [Abstract][Full Text] [Related]
6. Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study.
Silva SD; Agostini M; Nishimoto IN; Coletta RD; Alves FA; Lopes MA; Kowalski LP; Graner E
Oral Oncol; 2004 Aug; 40(7):688-96. PubMed ID: 15172638
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
Homma A; Furuta Y; Oridate N; Nakano Y; Kohashi G; Yagi K; Nagahashi T; Yagi K; Nagahashi T; Fukuda S; Inoue K; Inuyama Y
Clin Cancer Res; 1999 Apr; 5(4):801-6. PubMed ID: 10213215
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progression.
Rittà M; De Andrea M; Mondini M; Mazibrada J; Giordano C; Pecorari G; Garzaro M; Landolfo V; Schena M; Chiusa L; Landolfo S
Head Neck; 2009 Mar; 31(3):318-27. PubMed ID: 19072995
[TBL] [Abstract][Full Text] [Related]
9. Correlations between prognosis and regional biomarker profiles in head and neck squamous cell carcinomas.
Szentkúti G; Dános K; Brauswetter D; Kiszner G; Krenács T; Csákó L; Répássy G; Tamás L
Pathol Oncol Res; 2015 Jul; 21(3):643-50. PubMed ID: 25547827
[TBL] [Abstract][Full Text] [Related]
10. Second primary head and neck squamous cell carcinoma predicted by the glutathione S-transferase expression in healthy tissue in the direct vicinity of the first tumor.
Bongers V; Snow GB; de Vries N; Cattan AR; Hall AG; van der Waal I; Braakhuis BJ
Lab Invest; 1995 Oct; 73(4):503-10. PubMed ID: 7474922
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region.
Maula SM; Luukkaa M; Grénman R; Jackson D; Jalkanen S; Ristamäki R
Cancer Res; 2003 Apr; 63(8):1920-6. PubMed ID: 12702584
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of mitotic and apoptotic index and the DNA cytometry in head and neck cancer.
Smilek P; Dusek L; Veselý K; Rottenberg J; Kostrica R
Neoplasma; 2005; 52(3):199-207. PubMed ID: 15875080
[TBL] [Abstract][Full Text] [Related]
13. RACK1, an excellent predictor for poor clinical outcome in oral squamous carcinoma, similar to Ki67.
Wang Z; Zhang B; Jiang L; Zeng X; Chen Y; Feng X; Guo Y; Chen Q
Eur J Cancer; 2009 Feb; 45(3):490-6. PubMed ID: 19087901
[TBL] [Abstract][Full Text] [Related]
14. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.
Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A
Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296
[TBL] [Abstract][Full Text] [Related]
15. Squamous cell carcinoma of buccal mucosa: a 40-year review.
DeConde A; Miller ME; Palla B; Lai C; Elashoff D; Chhetri D; St John MA
Am J Otolaryngol; 2012; 33(6):673-7. PubMed ID: 22681929
[TBL] [Abstract][Full Text] [Related]
16. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma.
Kyzas PA; Geleff S; Batistatou A; Agnantis NJ; Stefanou D
J Pathol; 2005 Jun; 206(2):170-7. PubMed ID: 15846845
[TBL] [Abstract][Full Text] [Related]
17. Increased sensitivity to bleomycin in upper aerodigestive tract mucosa of head and neck squamous cell carcinoma patients.
Jin C; Jin Y; Wennerberg J; Rosenquist B; Mertens F
Mutat Res; 2008 Mar; 652(1):30-7. PubMed ID: 18243046
[TBL] [Abstract][Full Text] [Related]
18. Aberrant Kif2a and Ki67 expression predicts poor survival in laryngeal squamous cell carcinoma.
Zhang Q; Zhang W; Zhang J; Xu H; You Y
Auris Nasus Larynx; 2016 Aug; 43(4):433-9. PubMed ID: 26602436
[TBL] [Abstract][Full Text] [Related]
19. Tumor volume predicts outcome for advanced head and neck cancer treated with targeted chemoradiotherapy.
Doweck I; Denys D; Robbins KT
Laryngoscope; 2002 Oct; 112(10):1742-9. PubMed ID: 12368607
[TBL] [Abstract][Full Text] [Related]
20. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.
Langendijk JA; Slotman BJ; van der Waal I; Doornaert P; Berkof J; Leemans CR
Cancer; 2005 Oct; 104(7):1408-17. PubMed ID: 16130134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
